{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T06:48:28Z","timestamp":1693637308168},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:p>Corpus uteri cancer is the most common gynaecological cancer in women in Europe, but presents a relatively good prognosis. There were two main objectives in this study: estimate differences between countries in age-standardized net survival (NS) at 1 and 5 years in 2000\u20132004 and evaluate time trends in NS and excess mortality rates in 1992\u20132004. Data on corpus uteri malignant tumours (International Classification of Diseases for Oncology, third ed.: C54) were extracted from the EUROCARE database for six European Latin countries: Belgium, France, Italy, Portugal, Spain and Switzerland. NS was estimated for each country using the nonparametric estimator proposed by Pohar-Perme. Trends in NS and excess mortality rates up to 5 years after diagnosis were assessed using a multivariable parametric flexible modelling. The study analysed 25\u2009508 cases for the first objective and 43\u2009550 for the second. Age-standardized 1-year NS ranged from 88% (Portugal and Spain) to 93% (Switzerland), whereas 5-year survival ranged between 72% (Portugal) and 79% (Belgium and Switzerland). From 1992 to 2004, the NS increased in all countries with available information on this period (France, Italy, Spain and Switzerland). Also, in Belgium and Portugal, there was an increase in NS between 2000 and 2004. Improvements in survival were more evident for older ages (75 years). There were some differences in NS between the countries studied (maximum of 5% at 1 year and 7% at 5 years). The NS improved in all countries during the period studied and the differences between countries narrowed.<\/jats:p>","DOI":"10.1097\/cej.0000000000000294","type":"journal-article","created":{"date-parts":[[2016,12,21]],"date-time":"2016-12-21T18:21:56Z","timestamp":1482344516000},"page":"S100-S106","source":"Crossref","is-referenced-by-count":1,"title":["Trends in net survival from corpus uteri cancer in six European Latin countries: results from the SUDCAN population-based study"],"prefix":"10.1097","volume":"26","author":[{"given":"Lu\u00eds","family":"Antunes","sequence":"first","affiliation":[{"name":"North Region Cancer Registry of Portugal, Portuguese Oncology Institute, Porto, Portugal"}]},{"given":"Laurent","family":"Roche","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University Hospital of Lyon, Lyon"},{"name":"University of Lyon1, Villeurbanne"},{"name":"CNRS, UMR5558, Biometry and Evolutionary Biology Laboratory (LBBE), BioMaths-Health Department, Villeurbanne, France"}]},{"given":"Maria","family":"Jos\u00e9 Bento","sequence":"additional","affiliation":[{"name":"North Region Cancer Registry of Portugal, Portuguese Oncology Institute, Porto, Portugal"}]}],"member":"276","reference":[{"issue":"Suppl 2","key":"R1-20230901","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1016\/S0020-7292(12)60024-1","article-title":"Cancer of the corpus uteri","volume":"119","author":"Amant","year":"2012","journal-title":"Int J Gynaecol Obstet"},{"key":"R2-20230901","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.ejca.2013.09.002","article-title":"Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory","volume":"51","author":"Arnold","year":"2015","journal-title":"Eur J Cancer"},{"key":"R3-20230901","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/IGC.0b013e318244cedc","article-title":"Incidence and survival trends of uncommon corpus uteri malignancies in the Netherlands, 1989\u20132008","volume":"22","author":"Boll","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"R4-20230901","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejogrb.2012.10.028","article-title":"Increased incidence and improved survival in endometrioid endometrial cancer diagnosed since 1989 in the Netherlands: a population based study","volume":"166","author":"Boll","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R5-20230901","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ygyno.2009.06.011","article-title":"Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review","volume":"115","author":"Boruta","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"Suppl 1","key":"R7-20230901","first-page":"S3","article-title":"Trends in net survival from 15 cancers in six European Latin countries: the SUDCAN population-based study material","volume":"25","author":"Crocetti","year":"2016","journal-title":"Eur J Cancer Prev"},{"key":"R8-20230901","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1470-2045(13)70546-1","article-title":"Cancer survival in Europe 1999\u20132007 by country and age: results of EUROCARE \u2013 5-a population-based study","volume":"15","author":"De Angelis","year":"2014","journal-title":"Lancet Oncol"},{"key":"R10-20230901","first-page":"1817","article-title":"Patient age and biological aggressiveness of endometrial carcinoma","volume":"32","author":"Gonzalez-Rodilla","year":"2012","journal-title":"Anticancer Res"},{"key":"R11-20230901","first-page":"137","article-title":"Trends in survival from cancer of the corpus uteri in Switzerland","volume":"2","author":"Heinzelmann-Schwarz","year":"2014","journal-title":"Bulletin suisse du cancer"},{"key":"R13-20230901","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1541-0420.2011.01640.x","article-title":"On estimation in relative survival","volume":"68","author":"Perme","year":"2012","journal-title":"Biometrics"},{"issue":"Suppl 1","key":"R14-20230901","first-page":"S9","article-title":"New insights into survival trend analyses in cancer population-based studies: the SUDCAN methodology","volume":"25","author":"Uhry","year":"2016","journal-title":"Eur J Cancer Prev"},{"key":"R15-20230901","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.ejca.2014.02.020","article-title":"Trends in corpus uteri cancer mortality in member states of the European Union","volume":"50","author":"Weiderpass","year":"2014","journal-title":"Eur J Cancer"},{"key":"R17-20230901","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0140-6736(12)60442-5","article-title":"Contemporary management of endometrial cancer","volume":"379","author":"Wright","year":"2012","journal-title":"Lancet"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008469-201701001-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T00:06:20Z","timestamp":1693613180000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008469-201701001-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":13,"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000294","relation":{},"ISSN":["0959-8278"],"issn-type":[{"value":"0959-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}